Page 30 - REVISED GP Fall 2021 - ready for posting
P. 30
Table 2: COVID-19 patient screening interventions
~detect asymtompatic patients
***followup or patient call back
** screen to reduce chairside time
* all remote
Table 2 Data Summary Form
Post Appointment
*Pre-Appointment
Fever
Hour
SARS-CoV-2
Followup
Questionnaire
Clinic
1st Author Region Questionnaire Assignment
Tracking
Testing
Article
Temp
X
X
Gurgel [23]
Brazil
X
Taiwan
X
Chang [7]
X
X
X
X
X
X
X
United Kingdom
Barabari [8]
X
Amorim [12]
X
X
Brazil
X
Iran
Falahchai [11]
X
X
X
X
X
X
Israel
Abramovtiz [9]
X
Peng [3]
X
X
X
X
China
United States
Ather [24]
X
X
X
X
X
China
Ge [21]
X
X
X
Meng [6]
X
X
X
X
X
X
X
China
X
X
X
Brazil
X
Mattos [25]
X
X
Maltezou [26]
X
X
X
Greece
X
United States
TB Guide [22]
X
ADA Guide [10]
X
X
X
X
United States
X
X
X
X
X
United States
X
X
X
X
CDC Guide [4]
X
International
X
WHO Guide [27]
X
2/16
12/16 (75%)
5/16 (31%)
15/16 (94%)
12/16 (75%)
1/16 (6%)
4/16 (25%)
16/16 (100%) Risk X TOCC ` **Teletriage ~Targeted Non-Contact At Appointment Chairside ***48
Total 2/16 (13%) (13%)
Figure 2: COVID-19 patient screening flowchart recommendation
Table 2: COVID-19 patient screening interventions
~detect asymtompatic patients
***followup or patient call back
** screen to reduce chairside time `
* all remote
Table 2 Data Summary Form
*Pre-Appointment At Appointment Post Appointment
~Targeted ***48
Risk TOCC SARS-CoV-2 Non-Contact Fever Chairside Hour
Article 1st Author Region Questionnaire Assignment Tracking **Teletriage Testing Temp Clinic Questionnaire Followup
Gurgel [23] Brazil X X X X
Chang [7] Taiwan X X X X
Barabari [8] United Kingdom X X X X
Amorim [12] Brazil X X X
Falahchai [11] Iran X X X X
Abramovtiz [9] Israel X X X X
Peng [3] China X X X X
Ather [24] United States X X X X
Ge [21] China X X X X
Meng [6] China X X X X X X X
Mattos [25] Brazil X X X X X
Maltezou [26] Greece X X X X
TB Guide [22] United States X X
ADA Guide [10] United States X X X X X X
CDC Guide [4] United States X X X X X X X
WHO Guide [27] International X X X 2/16
Total 16/16 (100%) 15/16 (94%) 4/16 (25%) 12/16 (75%) 2/16 (13%) 12/16 (75%) 1/16 (6%) 5/16 (31%) (13%)
Figure 2: COVID-19 patient screening flowchart recommendation
were summarized in Table 2. The various to combine all raw information for ease Pre-appointment Questionnaires
strategies each article mentioned for of access remotely. Articles’ authorship, Pre-appointment questionnaires were
COVID-19 screening were tabulated by article type, search engine, article name, consistently used in all reported articles
citation frequency in Table 3. The patient and screening interventions were also (100%). The articles included questionnaire
screening process, based on COVID-19 recorded in this form. The final article samples from the United States, China,
risk assessment, was summarized list was reviewed twice after the draft to Australia, Italy, Brazil, Taiwan, and the
into a flowchart in Figure 2. Data was ensure accuracy. Ambiguous information United Kingdom. Approximately two-
symmetrically recorded in Microsoft was resolved by discussion and consensus thirds of the articles placed emphasis on
Excel. Notion (online platform) was used between the two authors. COVID-19 symptoms that included fever
www.nysagd.org l Fall 2021 l GP 30
